REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmaswiss D.O.O. Beograd (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pharmaswiss D.O.O. Beograd Profile Updated: July 06, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Swiss pharmaceutical company PharmaSwiss set up its Serbian unit in 2001. The Belgrade-based company is active in the wholesale and manufacture of pharmaceuticals and pharmaceutical products. It is an exclusive distributor and representative of Bristol Myers Squib, Ibsen, Wyeth-embrel, Reckitt Benckiser, Amgen, Astelas, Aspen, Lannacher, Mika Pharma and Eli Lilly.

Headquarters
Batajnicki Drum 5 A
Belgrade; Belgrade;

Contact Details: Purchase the Pharmaswiss D.O.O. Beograd report to view the information.

Website: http://www.bauschhealth.com

Basic Information
Total Employees:
Purchase the Pharmaswiss D.O.O. Beograd report to view the information.
Outstanding Shares:
Purchase the Pharmaswiss D.O.O. Beograd report to view the information.
Registered Capital:
Purchase the Pharmaswiss D.O.O. Beograd report to view the information.
Financial Auditors:
Purchase the Pharmaswiss D.O.O. Beograd report to view the information.
Incorporation Date:
February 27, 2001
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Procurator
Purchase this report to view the information.
Procurator
Purchase this report to view the information.
Procurator
Purchase this report to view the information.
Procurator
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Emitobanje Televizijskog I Radio Programa Rtl Tv D.O.O.Beograd - U Likvidaciji
10%
Company Performance
Financial values in the chart are available after Pharmaswiss D.O.O. Beograd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
12.33%
Total operating revenue
7.37%
Operating profit (EBIT)
121.62%
EBITDA
74.89%
Net Profit (Loss) for the Period
95.71%
Total assets
-4.44%
Total equity
5.48%
Operating Profit Margin (ROS)
9.74%
Net Profit Margin
9%
Return on Equity (ROE)
8.61%
Debt to Equity Ratio
0.13%
Quick Ratio
0.47%
Cash Ratio
-0.2%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?